ProSight

XRF-Guided Biopsy - A Transformative Modality in Prostate Cancer

Active Seed Startup Bat Yam Founded 2017-05

ProSight is a medical device startup spun out of the Weizmann Institute of Science, developing a real-time ex-vivo biopsy samples scanner, potentially transforming prostate cancer diagnosis based on new, never-used-before biomarkers, addressing the limitations in all biopsy procedures. Need: Current methods in prostate cancer biopsy often miss tumors and le…

SectorHealth Tech & Life Sciences
StageSeed
Total raised$6.0M
Employees6
Founded2017-05
HQBat Yam
Patents1
Confidence95
Sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technology
Simulation & ImagingBiologicalsArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProviders